Safety and Efficacy Study of an Anti-CD20 Monoclonal Antibody (AME-133v) to Treat Non-Hodgkin's Lymphoma
Clinical trial NCT00354926 · COMPLETED
Trial details
- NCT number
- NCT00354926
- Sponsor
- Applied Molecular Evolution
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2006-07-01
- Primary completion
- 2009-01-01
- Enrollment
- 67
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.